Home
Technology
News
Contact
About
- Learn More
- Disclosures

Select Page

2023 Form C-AR

by younghip | May 1, 2023 | Disclosures

This is the 2023 Form C-AR as required by the SEC.

2023 Form C-AR

Search

Recent Posts

CytexOrtho on Capital Hill
2023 Form C-AR
Breakthrough Device Designation from the FDA
October Newsletter
In WRAL Techwire

Recent Comments

Steve Scheftic on Breakthrough Device Designation from the FDA

Products are in development. This is potential future technology and not approved by the FDA and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of individual countries and regions and not guaranteed.

© 2022 Cytex Therapeutics, Inc now DBA CytexOrtho. All rights reserved